Abstract | OBJECTIVE: RESEARCH DESIGN AND METHODS: This was a prospective study of 3,810 community-living individuals older than 65 years (511 with type 2 diabetes) and free of CVD in 1992 when fetuin-A levels were measured. Participants were followed-up for incident CVD through June 2008. RESULTS: Mean age was 75 years, and 61% were women; 1,456 participants had an incident CVD event (248 among individuals with type 2 diabetes). The association of fetuin-A with CVD was modified by type 2 diabetes (P interaction = 0.02). Higher fetuin-A was associated with lower CVD risk among persons without type 2 diabetes [hazard ratio per SD 0.1 g/L higher fetuin-A, 0.93 (95% CI, 0.88-0.99)], whereas a trend in the opposite direction was observed among individuals with type 2 diabetes, although it was not statistically significant [1.07 (0.93-1.22)]. Among individuals without type 2 diabetes, similar effect modification was observed by obesity and insulin resistance. Consistently, higher fetuin-A was associated with lower CVD risk only in the subgroups without obesity or with HOMA-IR below the median [0.91 (0.85-0.97) and 0.87 (0.79-0.95), respectively]. CONCLUSIONS:
|
Authors | Majken K Jensen, Traci M Bartz, Kenneth J Mukamal, Luc Djoussé, Jorge R Kizer, Russell P Tracy, Susan J Zieman, Eric B Rimm, David S Siscovick, Michael Shlipak, Joachim H Ix |
Journal | Diabetes care
(Diabetes Care)
Vol. 36
Issue 5
Pg. 1222-8
(May 2013)
ISSN: 1935-5548 [Electronic] United States |
PMID | 23250801
(Publication Type: Journal Article, Research Support, N.I.H., Extramural)
|
Chemical References |
|
Topics |
- Aged
- Aged, 80 and over
- Cardiovascular Diseases
(epidemiology, metabolism)
- Diabetes Mellitus, Type 2
(epidemiology, metabolism)
- Female
- Fetuins
(metabolism)
- Humans
- Incidence
- Longitudinal Studies
- Male
- Risk Factors
|